Please login to the form below

Not currently logged in
Email:
Password:

Cancer therapy deal for Teva and Sinclair

Teva Pharmaceutical and Sinclair IS Pharma are to team up to promote episil, a spray therapy for ongoing supportive cancer care

Teva Pharmaceutical and Sinclair IS Pharma are to team up to promote episil (benzydamine hydrochloride) an oral spray for the treatment of pain in patients undergoing chemotherapy and radiotherapy during cancer treatment.

The licence agreement will see Teva hold exclusive commercialisation rights for episil in Germany, Spain, Poland, Switzerland and the Czech Republic, while Sinclair IS is to retain an option to co-promote the drug in Germany and Spain where it has its own direct sales force.

Financial details of the deal were not disclosed.

Teva said it expects to launch episil in the fourth quarter of 2011.

Chris Spooner, CEO of Sinclair IS, commented that similar agreements were likely for the company in the future. He said: "This is the first in what we expect to be a number of marketing and co-marketing partnerships. episil is a cornerstone of our supportive oncology portfolio and we look forward to working with Teva as we drive sales of this product."

Sinclair IS was formed earlier this year following the merger of Sinclair and IS Pharma.

31st August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GEM Marketing Ltd

GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics